A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 238 participants.

Also called NCT05496361

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 238 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05496361
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05496361. Randomized; single masking; primary purpose treatment. Start 2021-01-24 (actual); primary completion 2021-11-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke
Condition
AIS
Condition
Acute Ischemic Stroke
Condition
Large Vessel Occlusion
Condition
Thrombectomy
Intervention (Device)
Tianyi Revascularization Device
Intervention (Device)
Solitaire FR Revascularization Device
Lead sponsor
Suzhou Zenith Vascular SciTech Limited (class: industry)

Record details

Record id
cardio:ct-nct05496361
Content hash
65b65cb97a14dbcf649696f6b162225116e465a6438fbeed561a067649d274db